ACTR-12. PRELIMINARY SAFETY AND EFFICACY OF A PHASE II TRIAL OF 18F-DOPA PET-GUIDED, DOSE-ESCALATED RADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA

BACKGROUND: 18F-DOPA-PET thresholds reliably delineate areas of high-grade astrocytoma not otherwise recognized with standard MRI and may more accurately identify regions of aggressive, high-density disease. Herein we report the preliminary safety and feasibility data from an ongoing phase II study...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Laack, Nadia, Pafundi, Deanna, Anderson, S, Hunt, Christopher, Zakhary, Mark, Kaufmann, Timothy, Wan Chan Tseung, Hok Seum, Lowe, Val, Yan, Elizabeth, Kizilbash, Sani, Uhm, Joon, Hu, Leland, Sarkaria, Jann, Brown, Paul D, Buckner, Jan, Brinkmann, Debra
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216161/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.046
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares